drugset / Trial / NCT05075772

A Study in Healthy Men to Test How BI 765080 is Taken up in the Body When Given as an Injection Under the Skin Compared With an Infusion Into the Vein

NCT05075772 ↗

Phase 1 Completed 28 enrolled Boehringer Ingelheim
RandomizedParallel-groupOpen-labelTreatment

Summary

A study in healthy man to investigate the absolute bioavailability of 100mg BI 765080, once administered as subcutaneous (SC) injection and once administered as intravenous infusion.

Timeline

Start
2021-10-25
Primary completion
2022-03-11
Completion
2022-03-11

Drugs

EvaluationDrugModalityDoseRoute
Subject BI 765080 Unknown 100 mg Subcutaneous

Indications

No indication recorded.